Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

Université Laval

$27,000.00

Characterization of Changes in Thermal Pain Sensitivity Following Taxane-Based Chemotherapy for Breast Cancer: Using Mixed Methods to Elucidate Clinically Significant Changes

FY 2024-25

Summary
Chemotherapy, commonly used to treat cancers such as breast cancer, frequently results in difficult side effects. Among chemotherapy drugs, taxane are particularly known for their neurotoxic properties, which can result in chemo-induced peripheral neuropathy (CIPN). This condition commonly affects the fingers and toes, causing symptoms such as numbness, tingling, burning sensations and sensitivity to temperature changes. Unfortunately, there are currently no treatments to prevent or cure CIPN and options for symptom relief are limited. In severe cases, CIPN can reduce chemotherapy dosage, potentially compromising treatment effectiveness. Moreover, the measurement tools available often lack precision, which limits their ability to guide effective therapeutic decisions.This project will focus on understanding how sensitivity to heat and cold pain evolves during chemotherapy treatment. A mixed-methods approach will combine Quantitative Sensory Testing with patients qualitative feedback to provide a comprehensive perspective. Breast cancer patients will describe their experiences during sensitivity tests conducted before, immediately after and three months following chemotherapy.These descriptions will be combined with quantitative data to identify important changes, helping to improve treatment decisions with more effective and personalized approaches.In the long term, this research aims to improve oncology care by advancing the understanding of chemotherapy side effects. By contributing insights that make treatments more tolerable and tailored to individual patient needs, this work has the potential to enhance quality of life for those with cancer, helping oncologists to anticipate and manage the side effects of chemotherapy more effectively.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
529739
Name
Auger Charles-Antoine
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterization of Changes in Thermal Pain Sensitivity Following Taxane-Based Chemotherapy for Breast Cancer: Using Mixed Methods to Elucidate Clinically Significant Changes
Programtype2
Studentship Programs
Orgnameinp2
Université Laval
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Chemotherapy-Induced Neuropathy; Cold Pain Threshold; Heat Pain Threshold; Mixed Methods Design; Neurotoxicity; Oncology; Qualitative; Quantitative Sensory Testing; Taxane-Based Chemotherapy
Abstract
Chemotherapy, commonly used to treat cancers such as breast cancer, frequently results in difficult side effects. Among chemotherapy drugs, taxane are particularly known for their neurotoxic properties, which can result in chemo-induced peripheral neuropathy (CIPN). This condition commonly affects the fingers and toes, causing symptoms such as numbness, tingling, burning sensations and sensitivity to temperature changes. Unfortunately, there are currently no treatments to prevent or cure CIPN and options for symptom relief are limited. In severe cases, CIPN can reduce chemotherapy dosage, potentially compromising treatment effectiveness. Moreover, the measurement tools available often lack precision, which limits their ability to guide effective therapeutic decisions.This project will focus on understanding how sensitivity to heat and cold pain evolves during chemotherapy treatment. A mixed-methods approach will combine Quantitative Sensory Testing with patients qualitative feedback to provide a comprehensive perspective. Breast cancer patients will describe their experiences during sensitivity tests conducted before, immediately after and three months following chemotherapy.These descriptions will be combined with quantitative data to identify important changes, helping to improve treatment decisions with more effective and personalized approaches.In the long term, this research aims to improve oncology care by advancing the understanding of chemotherapy side effects. By contributing insights that make treatments more tolerable and tailored to individual patient needs, this work has the potential to enhance quality of life for those with cancer, helping oncologists to anticipate and manage the side effects of chemotherapy more effectively.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Auger, Charles-Antoine
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~